The effect of levonorgestrel and melatonin treatments on plasma oxidant-antioxidant system, and lipid / lipoprotein levels in female rats

This study was carried out in order to determine the effects of levonorgestrel (LNG) and progestin derivatives, alone and in combination with melatonin (MEL), on the plasma oxidant-antioxidant system, and also lipid and lipoprotein levels, in the rat model. Female rats were divided into 4 groups according to subcutaneous treatment with LNG (5 mg/kg/day), MEL (25 mg/kg/day) and a LNG-MEL combination (5 mg LNG/25 mg MEL/kg/day) for 5 consecutive days, and a control group. Following the treatment period, malondialdehyde (MDA), conjugated dienes (CD), thiol (SH) and glutathione peroxidase (GPx) values, as the components of the oxidant-antioxidant system, and also triglyceride (TG) and cholesterol (TC, HDL-C, LDL-C) levels were measured in plasma obtained from the rats. Statistical comparisons were made using ANOVA and post-ANOVA tests. There were no significant differences in respect of any of the measured parameters between the controls and the MEL group. Although there were no significant differences in TG and HDL-C, MDA and CD levels were found to be higher, but SH and GPx values lower in the LNG group than in the control and MEL groups. On the other hand, the LNG treatment along with MEL resulted in significant decreases in MDA, CD, TC, LDL-C levels and elevations in SH and GPx in respect of the LNG group, and these values measured in the LNG-MEL group were not different from those of the control and MEL groups. In conclusion, the use of MEL together with synthetic sex steroids, which may lead to oxidative stress and induce the risk of cardiovascular disease (CVD), may play an important role in reducing the risk of CVD, through the protection of the antioxidant system.

PDF

___

1. Speroff L, Glass RH, Kase NG. Clinical Gynecologic Endocrinology and Infertility. Williams and Wilkins, Baltimore, 1989, pp:461-98. 2. Kse K, DoÛan P, zesmi . The effect of contraceptive steroids on hepatic cholesterol metabolism in female rats (I). Biochem Mol Biol Int 30: 237-43, 1993 3. Kse K, DoÛan P, zesmi . The effect of contraceptive steroids on plasma lipoprotein metabolism in female rats (II). Biochem Mol Biol Int 30: 245-52, 1993. 4. Fotherby K. Oral contraceptives, lipids and cardiovascular disease. Contraception 31: 367-94, 1985. 5. Meade TW. Risks and mechanisms of cardiovascular events in users of oral contraceptives. Am J Obstet Gynecol 158: 1646-52, 1988. 6. Brown KH, Hammond CB. The risks and benefits of oral contraceptives. Adv Intern Med 34: 285-305, 1989. 7. Kostner JF, Biemond P, Stam H. Lipid peroxidation and myocardial ischemic damage : Cause or consequence? Basic Res Cardiol 82: 253-60, 1987. 8. Piotrowski JJ, Hunter GC, Eskelson CD, Dubick MA, Bernhard VM. Evidence for lipid peroxidation in atherosclerosis. Life Sci 46: 715-21, 1990. 9. Kse K, DoÛan P, zesmi . Contraceptive steroids increase erythrocyte lipid peroxidation in female rats. Contraception 47: 421-25, 1993. 10. Jendryczko A, Tomal J, Janosz P. Effects of two low-dose oral contraceptives on erythrocyte superoxide dismutase, catalase and glutathione peroxidase activities. Zentralb Gynakol 115: 469-72, 1993. 11. Massafra C, Buonocore G, Berni S, Gioia D, Giulini A, Vezzosi P. Antioxidant erythrocyte enzyme activities during oral contraception Contraception 47: 590-6, 1993. 12. Poeggeler B, Reiter RJ, Tan D-X, Chen L-D, Manchester LC. Melatonin, hydroxyl radical-mediated oxidative damage, and aging: A hypothesis. J. Pineal Res 14:151-68; 1993. 13. Pierpaoli W, DallÕAra A, Pedrino E, Regelson W. The pineal gland and aging: The effects of melatonin and pineal grafting on the survival of older mice. Ann NY Acad Sci 621: 291-313, 1991. 14. Koster JF, Biemond P, Swaat AJG.Intracellular and extracellular sulphydril levels in rheumatoid arthritis. Ann Rheum Dis 45: 44-6, 1986. 15. Wong SHY, Knight JA, Hopfer SM, Zaharia O, Leach CN, Sunderman FW. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 33: 214-20, 1987. 16. Kse K, DoÛan P, Gndz Z, Dßnsel R, Utaß C. Oxidative stress in hemodialyzed patients and the longterm effects of dialyzer reuse practice. Clin Biochem 30: 601-6, 1997. 17. Mooradian AD. Increased serum conjugated dienes in elderly diabetic patients. JAGS 39: 571-4, 1991. 18. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70: 158-69, 1967. 19. Ellefson RD, Caraway WT. Lipids and Lipoproteins. Fundamentals of Clinical Chemistry (Ed. NW. Tietz) Saunders Comp. Philadelphia, London, Toronto 1976, pp: 474-538. 20. Lopez-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins seperated by three different methods. Clin Chem 23: 882-5, 1977. 21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein-cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499- 502, 1972. 22. Dawson-Saunders B, Trapp RG. Basic and Clinical Biostatistics, Appleton- Lange, East Norwalk, Connecticut 1990, pp: 124-41. 23. Yagi K. Female hormones act as natural antioxidants-a survey of our research. Acta Biochem Pol 44: 701-9, 1997. 24. Durand P, Prost M, Blache D. Folic acid deficiency enhances oral contraceptive induced platelet hyperactivity. Arterioscler Thromb Vasc Biol 17: 1939-46, 1997. 25. Ledwozyw A, Michalack J, Stepien A, Kadziolka A. The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation product during human atherosiclerosis. Clin Chem Acta 155: 275-84, 1986. 26. Kelly F. Use of antioxidants in the prevention and treatment of disease. JIFCC 10: 21-3, 1998. 27. Khokka R, Wolfe B. Hypotriglyceridemic effects of levonorgestrel in rats. Atherosclerosis 52: 329-38, 1984. 28. Tkocz R, Hillesheim HG, Schmidt G, Hoffmann H. Serum lipoprotein changes in female rats treated with progesterone or synthetic gestagens alone or in combination with estradiol. 2. Serum triglycerides and hepatic triglyceride release. Exp Clin Endocrinol 92: 7-12, 1988. 29. Tkocz R, Hillesheim HG, Schmidt G, Hoffmann H. Serum lipoprotein changes in female rats treated with progesterone or synthetic gestagens alone or in combination with estradiol. 1. Total and fractioned cholesterol and lipoprotein pattern. Exp Clin Endocrinol 91: 319- 26, 1988. 30. La Rosa JC. The varying effects of progestins on lipid levels and cardiovascular disease. Am J Obstet Gynecol 158: 1621-9, 1988. 31. Manning JM, Edwards IJ, Wagner WD, Wagner JD, Adams MR, Parks JS. Effects of contraceptive estrogen and progestin on the atherogenic potential of plasma LDLs in cynomolgus monkeys. Arterioscler Thromb Vasc Biol 17: 1216-23, 1997.
32. Jialal I, Devaraj S. Low-density lipoprotein oxidation, antioxidants, and atheriosclerosis: a clinical biochemistry perspective. Clin Chem 42: 498-506, 1996. 33. Montilla PL, Vargas JF, Tunez IF; Munoz de Agueda MC. Valdelvira ME, Cabrera ES. Oxidative stress in diabetic rats induced by streptozotocin : Protective effects of melatonin. J Pineal Res 25: 94-100, 1998. 34. Akbulut KG, Gon IB, Akbulut H. Differential effects of pharmacological doses of melatonin on malondialdehyde and glutathione levels in young and old rats. Gerontology 45: 67-71, 1999. 35. Kelly MR, Lov G. Melatonin inhibits oxidative modification of human lowdensity lipoprotein. J Pineal Res 22: 203-9, 1997. 36. Abuja PM, Liebmann P, Hayn M, Schauenstein K, Esterbauer H. Antioxidant role of melatonin in lipid peroxidation of human LDL. FEBS Lett 413: 289-93, 1997. 37. Barlow-Walden LR, Reiter RJ, Abe M, Pablos A, Menendez Pelaez LD; Chen B, Poeggeler B. Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 26: 497-502, 1995. 38. Pigeolet E, Remacle R: Susceptibility of glutathione peroxidase to proteolysis after oxidative alterations by peroxides and hydroxyl radicals. Free Rad Biol Med 11: 191-5, 1991.